Dr. Sacks was alleged to have prescribed the opioids Butrans, Hysingla and OxyContin to Medicare beneficiaries in exchange for receiving paid speaking and consulting work from Purdue Pharma, the department said. He was also alleged to have prescribed the opioids Lazanda and Nucynta, as well as the nerve pain drug Gralise, to Medicare members in exchange for similar work from Depomed Inc.
The settlement included no determination of liability, the department said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.